British Medical Association says review into gender identity services was ‘robust’ after previously rejecting findings

The trade union representing doctors across the UK has dropped its opposition to the findings of the Cass review of gender identity services across the NHS.

The British Medical Association (BMA) had previously rejected the findings of the landmark review of transgender healthcare, with the medical body refusing to endorse the report’s findings.

In-depth study also reveals patients from black African and Caribbean backgrounds are less likely to receive timely care

People from black backgrounds in England are twice as likely to experience strokes as their white counterparts, while also being less likely to receive timely care, according to the largest study of its kind.

The study, conducted by researchers at King’s College London and presented at the European Stroke Organisation conference, analysed 30 years of stroke incidents from the South London Stroke Register, one of the longest-running population-based stroke registers in the world.

Injectable pembrolizumab can treat several types of cancer and can be administered in under two minutes

Thousands of patients across England each year will benefit from a new immunotherapy treatment that can be used for several types of cancer, the NHS has announced.

The injectable form of pembrolizumab, which can be administered in under two minutes, kills cancer cells by blocking a protein called PD-1, which acts as a brake on immune responses, allowing the immune system to recognise and attack cancer cells.

Charity says starting specialised care after first miscarriage instead of third reduces risk of future losses

Giving women access to specialised care after their first miscarriage could prevent about 10,000 pregnancy losses a year across the UK, according to a study.

Currently, women in England, Wales and Northern Ireland are eligible for specialist care on the NHS for early baby losses after they have had a minimum of three miscarriages.